Two transcription factors, E1AF and N-myc, correlate with the invasiveness of neuroblastoma cell lines

Japanese Journal of Cancer Research

Volumn 88, Issue 4, 1997, Pages 394-400

  Taguchi, Kazunori ^a,b   Yoshida, Koichi ^a   Sasaki, Fumiaki ^b   Fujinaga, Kei ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

E1AF; Invasion; MMP; N myc; Neuroblastoma

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE; MEMBRANE PROTEIN; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSCRIPTION FACTOR;

ARTICLE; CANCER INVASION; GENE ACTIVATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; ONCOGENE C MYB; ONCOGENE MYC; PHENOTYPE; PRIORITY JOURNAL;

EID: 0030915188     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00395.x     Document Type: Article

References (51)

1. Kohl, N. E., Kanda, N., Schreck, R. R., Bruns, G., Latt, S. A., Gilbert, F. and Alt, F. W. Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell 35, 359-367 (1983).
2. Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E. and Bishop, J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science, 224, 1121-1124 (1984).
3. Charron, J., Malynn, B. A., Fisher, P., Stewart, V., Jeannotte, L., Goff, S. P., Robertson, E. J. and Alt, F. W. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev., 6, 2248-2257 (1992).
4. Stanton, B. R., Perkins, A. S., Tessarollo, L., Sassoon, D. A. and Parada, L. F. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev., 6, 2235-2247 (1992).
5. Nakagawara, A., Ikeda, K., Yokoyama, T., Tsuda, T. and Higashi, K. Surgical aspects of N-myc oncogene amplifi- cation of neuroblastoma. Surgery, 104, 34-40 (1988).
6. Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y. and Hammond, D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313, 1111-1116 (1985).
7. Schwab, M., Alitaro, K., Klemppauer, K. H., Varmus, H. E., Bishop, J. M., Gilbert, F., Brodeur, G., Goldstein, M. and Trent, J. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature, 305, 245-248 (1983).
8. Nakagawara, A., Ikeda, K., Tsuda, T. and Higashi, K. N-myc oncogene amplification and prognostic factors of neuroblastoma in children. J. Pediatr. Surg., 22, 895-898 (1987).
9. Tsuda, T., Obara, M., Hirano, H., Gotoh, S., Kubomura, S., Higashi, K., Kuroiwa, A., Nakagawara, A., Nagahara, N. and Shimizu, K. Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas. Cancer, 60, 820-826 (1987).
10. Thiele, C. J., Reinolds, C. P. and Israel, M. A. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature, 313, 404-406 (1985).
11. Matrisian, L. M. Metalloproteinases and their inhibitors in connective tissue remodeling. Trend. Genet., 6, 121-125 (1990).
12. Alexander, C. M. and Werb, Z. Proteinases and extracellular matrix remodeling. Curr. Opin. Cell Biol., 1, 974-982 (1989).
13. Woessner, J. F. J. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J., 5, 2145-2154 (1991).
14. Sato, H., Kida, Y., Mai, M., Endo, Y., Sasaki, T., Tanaka, J. and Seiki, M. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene, 7, 77-87 (1992).
15. Bernhard, E. J., Gruber, S. B. and Muschel, R. J. Direct evidence linking expression of matrix metalloproteinase 9 (92kD gelatinase/collagenase) to metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. USA, 91, 4293-4297 (1994).
16. Liotta, L. A., Steep, P. S. and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-336 (1991).
17. Sato, H. and Seiki, M. Regulatory mechanism of 92kD type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene, 8, 395-405 (1993).
18. Gaire, M., Magbanua, Z., Mcdonnel, S., McNeil, L., Lovett, D. H. and Matrisian, L. M. Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J. Blol. Chem., 269, 2032-2040 (1994).
19. Gutman, A. and Wasylyk, B. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J., 9, 2241-2246 (1990).
20. Nerlov, C., Rørth, P., Blasi, F. and Johnsen, M. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene, 6, 1583-1592 (1991).
21. Wasylyk, C., Gutman, A., Nicholson, R. and Wasylyk, B. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J., 10, 1127-1134 (1991).
22. Higashino, F., Yoshida, K., Fujinaga, Y., Kamio, K. and Fujinaga, K. Isolation of a cDNA encoding the adenovirus E1A enhancer binding protein: a new human member of the ets oncogene family. Nucleic Acids Res., 21, 547-553 (1993).
23. Yoshida, K., Higashino, F. and Fujinaga, K. Transcriptional regulation of the adenovirus E1A gene. In "The Molecular Repertoire of Adenoviruses III," eds. W. Doerfler and P. Böhm, Curr. Top. Microbiol. Immunol. 199/III, pp. 113-130 (1995). Springer, Berlin.
24. Kaneko, Y., Yoshida, K., Handa, M., Toyoda, Y., Nishihira, H., Tanaka, Y., Sasaki, Y., Ishida, S., Higashino, F. and Fujinaga, K. Fusion of an ETS-family gene, E1AF, to EWS by t(17; 22) (q12; q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chromosomes Cancer, 15, 115-121 (1996).
25. Higashino, F., Yoshida, K., Noumi, T., Seiki, M. and Fujinaga, K. Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene, 10, 1461-1463 (1995).
26. Kaya, M., Yoshida, K., Higashino, F., Mitaka, T., Ishii, S. and Fujinaga, K. A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells. Oncogene, 12, 221-227 (1996).
27. Kato, H., Kato, T., Tomishige, H., Miyatani, Y., Aono, S., Nishikawa, O., Hashimoto, K., Kurosawa, Y. and Kishikawa, T. Analysis of N-myc gene amplification and rearrangement in neuroblastoma cells and tumors. J. Jpn. Soc. Pediatr. Surg., 26, 1110-1117 (1990).
28. Kato, H., Okamura, K., Kurosawa, Y., Kishikawa, T. and Hashimoto, K. Characterization of DNA rearrangements of N-myc gene amplification in three neuroblastoma cell lines by pulsed-field gel electrophoresis. FEBS Lett., 250, 529-535 (1989).
29. Livingstone, A., Mairs, R. J., Russell, J., O'Donoghue, J., Gaze, M. N. and Wheldon, T. E. N-myc gene copy number in neuroblastoma cell lines and resistance to experimental treatment. Eur. J. Cancer, 30, 382-389 (1994).
30. Sugimoto, T., Horii, Y., Hayashi, Y., Inazawa, J. and Sawada, T. N-myc amplification and over-expression in various cell lines from solid malignant tumors in childhood. J. Clin. Exp. Med., 156, 239-240 (1991).
31. Sekiguchi, M., Oota, T., Sakakibara, K., Inui, N. and Fujii, G. Establishment and characterization of a human neuroblastoma cell line in tissue culture. Jpn. J. Exp. Med., 49, 67-83 (1979).
32. LaQuaglia, M. P., Kopp, E. B., Spengler, B. A., Meyers, M. B. and Biedler, J. L. Multidrug resistance in human neuroblastoma cells. J. Pediatr. Surg., 26, 1107-1112 (1991).
33. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, A., Kozlowaki, J. M. and McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47, 3239-3245 (1987).
34. Schreiber, E., Matthias, P., Muller, M. M. and Schaffner, W. Rapid detection of octamer binding proteins with miniextracts, prepared from a small number of cells. Nucleic Acids Res., 17, 6419 (1989).
35. Shindo, M., Higashino, F., Kaya, M., Yasuda, M., Funaoka, K., Hanzawa, M., Hida, K., Kongo, T., Amemiya, A., Yoshida, K. and Fujinaga, K. Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines. Am. J. Pathol., 148, 693-700 (1996).
36. Grøndahl-Hansen, J., Christensen, J., Rosenquist, C., Brünner, N., Mouridsen, H. T., Danø, K. and Blichert-Toft, T. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res., 53, 2513-2521 (1993).
37. Boyd, D., Florent, G., Kim, P. and Brattain, M. Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines. Cancer Res., 48, 3112-3116 (1988).
38. Quax, P. H. A., van Leeuwen, R. T. J., Verspaget, H. W. and Verheijen, J. H. Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines. Cancer Res., 50, 1488-1494 (1990).
39. Danø, K., Andreasen, P. A., Grøndahl-Hansen, J., Kristensen, P., Nielsen, L. S. and Skriver, L. Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res., 44, 139-266 (1985).
40. Tsuchiya, Y., Sato, H., Endo, Y., Okada, Y., Mai, M., Sasaki, T. and Seiki, M. Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo. Cancer Res., 53, 1397-1402 (1993).
41. DeClerck, Y. A., Ferez, N., Shimada, H., Boone, T. C., Langley, K. E. and Taylor, S. M. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res., 52, 701-708 (1992).
42. Stetler-Stevenson, W. G., Krutzsch, H. C. and Liotta, L. A. Tissue inhibitor of metalloproteinase (TIMP-2): a new member of the metalloproteinase family. J. Biol. Chem., 264, 17374-17378 (1989).
43. Goldberg, G. I., Manner, B. L., Grant, G. A., Eisen, A. Z., Wilhelm, S. and He, C. Human 72-kDa type IV collagenase forms a complex with tissue inhibitor of metalloproteinases designated TIMP-2. Proc. Natl. Acad. Sci. USA, 86, 8207-8211 (1989).
44. Liotta, L. A. Tumor invasion and metastasis - role of the extracellular matrix. Cancer Res., 46, 1-7 (1986).
45. Schwab, M., Varmus, H. E., Bishop, J. M., Grzeschik, K.-H., Naylor, S. L., Sakaguchi, A. Y., Brodeur, G. and Trent, J. Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature, 308, 288-291 (1984).
46. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. and Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature, 370, 61-65 (1994).
47. Nomura, H., Sato, H., Seiki, M., Mai, M. and Okada, Y. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res., 55, 3263-3266 (1995).
48. Welgus, H. G., Jeffrey, J. J., Eizen, A. Z., Roswit, W. T. and Stricklin, G. P. Human skin fibroblast collagenase: interaction with substrate and inhibitor. Coll. Relat. Res., 5, 167-179 (1985).
49. Schultz, R. M., Silberman, S., Persky, B., Bajkowski, A. S. and Carmichael, D. F. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res., 48, 5539-5545 (1988).
50. Albini, A., Melchiori, A., Santi, L., Liotta, L. A., Brown, P. D. and Stetler-Stevenson, W. G. Tumor cell invasion inhibited by TIMP-2. J. Natl. Cancer Inst., 83, 775-779 (1991).
51. Edwards, D. R., Rocheleau, H., Sharma, R. R., Wills, A. J., Cowie, A., Hassell, J. A. and Heath, J. K. Involvement of API and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochim. Biophys. Acta, 1171, 41-55 (1992).